Decision support during electronic prescription to stem antibiotic overuse for acute respiratory infections: a long-term, quasi-experimental study

Table 2 Odds of guideline concordant prescription for ARI and CDSS exposure

Antibiotic Prescribed During ARI Visit	No. of visits (n, %)^a	Guideline Concordant (n, %)^b	Unadjusted, odds ratio (95% CI)^c	Adjusted for age, sex, race, and symptoms (Logistic Regression model), odds ratio (95% CI)^c
Azithromycin^d	130 (11.5)	81 (62.3)	9.5 (6.3–14.3)	8.8 (5.7–13.6)
Fluoroquinolone, pre-withdrawal	44 (3.9)	39 (88.6)	36.5 (13.8–96.7)	24.4 (9.0–66.3)
Fluoroquinolone, post-withdrawal	115 (10.2)	59 (51.3)	7.5 (4.8–11.8)	5.5 (3.5–8.8)
All Other Antibiotics^d	746 (66.0)	106 (14.2)
No Antibiotics	96 (8.5)	95 (99.0)

^aNumber of visits for which the antibiotic is prescribed / Total number of visits (n = 1131)
^bNumber of concordant visits for which the antibiotic is prescribed / Number of total visits for which the antibiotic is prescribed
^cVersus “All Other Antibiotics”
^dFor the groups “Azithromycin” and “All Other Antibiotics”, data are shown for the entire 8 year study period

ISSN: 1471-2334